The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Practice Parameter: Pharmacological treatment of migraine headache in children and adolescents [RETIRED]: Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society
Open accessAbstract
OBJECTIVE: To review evidence on the pharmacologic treatment of the child with migraine headache. METHODS: The authors reviewed, abstracted, and classified relevant literature. Recommendations were based on a four-tiered scheme of evidence classification. Treatment options were separated into medications for acute headache and preventive medications. RESULTS: The authors identified and reviewed 166 articles. For acute treatment, five agents were reviewed. Sumatriptan nasal spray and ibuprofen are effective and are well tolerated vs placebo. Acetaminophen is probably effective and is well tolerated vs placebo. Rizatriptan and zolmitriptan were safe and well tolerated but were not superior to placebo. For preventive therapy, 12 agents were evaluated. Flunarizine is probably effective. The data concerning cyproheptadine, amitriptyline, divalproex sodium, topiramate, and levetiracetam were insufficient. Conflicting data were found concerning propranolol and trazodone. Pizotifen, nimodipine, and clonidine did not show efficacy. CONCLUSIONS: For children (>age 6 years), ibuprofen is effective and acetaminophen is probably effective and either can be considered for the acute treatment of migraine. For adolescents (>12 years of age), sumatriptan nasal spray is effective and should be considered for the acute treatment of migraine. For preventive therapy, flunarizine is probably effective and can be considered, but is not available in the United States. There are conflicting or insufficient data to make any other recommendations for the preventive therapy of migraine in children and adolescents. For a clinical problem so prevalent in children and adolescents, there is a disappointing lack of evidence from controlled, randomized, and masked trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Drugs for preventing migraine headaches in children
Victor, S., & Ryan, S. W. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002761 · Cited by 108
RetractedThe International Classification of Headache Disorders: 2nd edition
Olesen, J., Goadsby, P., & Steiner, T. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00590-8 · Cited by 5,049
Sorge, F., Simone, R. D., Marano, E., Nolano, M., Orefice, G., & Carrieri, P. (1988) · Cephalalgia · doi:10.1046/j.1468-2982.1988.0801001.x · Cited by 3,465
Stewart, W. F. (1992) · JAMA · doi:10.1001/jama.267.1.64 · Cited by 1,583
Silberstein, S. D. (2000) · Neurology · doi:10.1212/wnl.55.6.754 · Cited by 1,360
Self-citationA double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Lewis, D. W., Ashwal, S., Dahl, G., Dorbad, D., Hirtz, D., Prensky, A., & Jarjour, I. (2002) · Neurology · doi:10.1212/wnl.59.4.490 · Cited by 398
Self-citationAge- and Sex-specific Incidence Rates of Migraine with and without Visual Aura
Stewart, W. F., Linet, M. S., Celentano, D. D., Natta, M. V., & Ziegler, D. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116014 · Cited by 378
Hamalainen, M. L., Hoppu, K., Valkeila, E., & Santavuori, P. (1997) · Neurology · doi:10.1212/wnl.48.1.103 · Cited by 350
Vahlquist, B. (1955) · International Archives of Allergy and Immunology · doi:10.1159/000228238 · Cited by 302
Cited by
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Ibuprofen: pharmacology, efficacy and safety
Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 667
Dodick, D. W. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30478-1 · Cited by 557
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine
Powers, S. W., Coffey, C. S., Chamberlin, L. A., Ecklund, D. J., Klingner, E. A., Yankey, J. W., Korbee, L. L., Porter, L. L., & Hershey, A. D. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610384 · Cited by 370
Self-citationLi, B. U., Lefevre, F., Chelimsky, G. G., Boles, R. G., Nelson, S. P., Lewis, D. W., Linder, S. L., Issenman, R. M., & Rudolph, C. D. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318173ed39 · Cited by 290
Self-citation
Metadata
- Authors
- Lewis, D., Ashwal, S., Hershey, A., Hirtz, D., Yonker, M., & Silberstein, S.
- Venue
- Neurology
- Published
- 2004-12-28
- Volume
- 63
- Issue
- 12
- Pages
- 2215-2224
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2152007006
- Cited by
- 440
- References
- 29
- FWCI
- 16.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Practice Parameter: Pharmacological treatment of migraine headache in children and adolescents [RETIRED]: Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. https://app.cochat.ai/papers/10.1212/01.wnl.0000147332.41993.90
- The paper
- Lewis, D., Ashwal, S., Hershey, A., Hirtz, D., Yonker, M., & Silberstein, S. (2004). Practice Parameter: Pharmacological treatment of migraine headache in children and adolescents [RETIRED]: Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. https://doi.org/10.1212/01.wnl.0000147332.41993.90
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.